- Report
- October 2024
- 70 Pages
Europe
From €865EUR$950USD£741GBP
- Report
- July 2024
- 132 Pages
Global
From €865EUR$950USD£741GBP
- Report
- July 2024
- 132 Pages
Global
From €865EUR$950USD£741GBP
- Report
- July 2024
- 132 Pages
Global
From €865EUR$950USD£741GBP
- Report
- April 2024
- 132 Pages
Global
From €865EUR$950USD£741GBP
- Report
- April 2024
- 132 Pages
Global
From €865EUR$950USD£741GBP
- Report
- March 2024
- 132 Pages
Global
From €865EUR$950USD£741GBP
- Report
- January 2024
- 132 Pages
Global
From €865EUR$950USD£741GBP
- Report
- January 2024
- 132 Pages
Global
From €865EUR$950USD£741GBP
- Report
- March 2023
- 132 Pages
Global
From €865EUR$950USD£741GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£741GBP
- Report
- November 2021
- 1032 Pages
Global
From €4551EUR$5,000USD£3,901GBP
- Report
- September 2024
- 280 Pages
Global
From €2416EUR$2,655USD£2,071GBP
- Report
- October 2022
- 356 Pages
Global
From €3495EUR$3,840USD£2,996GBP
- Report
- September 2022
- 141 Pages
Global
From €3249EUR$3,570USD£2,785GBP
- Book
- April 2020
- 608 Pages
- Book
- March 2010
- 784 Pages

The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured in a variety of ways.
Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs.
Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more